Earnings Calendar - Nov 13, 2025
Showing earnings announcements on Nov 13, 2025
Name | Price | % Change | Company | Market Cap | EPS / Forecast | Revenue / Forecast | Time | Analyst Consensus | Smart Score | Follow |
|---|---|---|---|---|---|---|---|---|---|---|
 | $104.03 | After: +0.04% | Walt Disney | $176.45B | xxxxxxxxxxxxx | |||||
 | $117.94 | After: -0.02% | Cisco Systems | $442.36B | xxxxxxxxxxxxx | |||||
 | $530.27 | After: <+0.01% | Applied Materials | $428.57B | xxxxxxxxxxxxx | |||||
 | $26.50 | After: +0.52% | JD | $35.74B | xxxxxxxxxxxxx | |||||
 | $3.07 | After: 0% | Virgin Galactic Holdings | $459.34M | xxxxxxxxxxxxx | |||||
 | $1.45 | After: 0% | BioNano Genomics | $17.43M | xxxxxxxxxxxxx | |||||
 | $15.66 | After: -0.26% | Nu Holdings | $64.87B | xxxxxxxxxxxxx | |||||
 | $54.50 | Tencent Holdings | $483.58B | xxxxxxxxxxxxx | ||||||
 | $7.41 | After: +0.13% | Ondas | $4.22B | xxxxxxxxxxxxx | |||||
 | $3.47 | After: 0% | Keel Infrastructure | $2.24B | xxxxxxxxxxxxx | |||||
 | $0.44 | Vaxart | $106.12M | xxxxxxxxxxxxx | ||||||
 | $6.34 | After: +0.16% | Red Cat Holdings | $977.37M | xxxxxxxxxxxxx | |||||
 | $7.71 | After: +0.52% | POET Technologies | $1.35B | xxxxxxxxxxxxx | |||||
 | $14.90 | After: 0% | Bilibili | $6.08B | xxxxxxxxxxxxx | |||||
 | $11.54 | After: 0% | Canadian Solar | $759.43M | xxxxxxxxxxxxx | |||||
 | $5.56 | After: 0% | Paysafe | $281.44M | xxxxxxxxxxxxx | |||||
 | $1.08 | After: 0% | Tvardi Therapeutics | $15.34M | xxxxxxxxxxxxx | |||||
 | $8.56 | After: 0% | Stratasys | $762.01M | xxxxxxxxxxxxx | |||||
 | $115.33 | After: 0% | NICE | $6.70B | xxxxxxxxxxxxx | |||||
 | $7.82 | After: 0% | Immunic | $108.61M | xxxxxxxxxxxxx | |||||
 | $2.93 | After: +0.34% | Vuzix | $251.55M | xxxxxxxxxxxxx | |||||
 | $3.70 | After: 0% | TMC the metals company Inc. | $1.67B | xxxxxxxxxxxxx | |||||
 | $0.83 | After: 0% | Daré Bioscience | $16.58M | xxxxxxxxxxxxx | |||||
 | $8.76 | After: 0% | Sagimet Biosciences, Inc. Class A | $562.94M | xxxxxxxxxxxxx | |||||
 | $1.15 | After: -1.74% | Co-Diagnostics | $8.04M | xxxxxxxxxxxxx | |||||
 | $33.47 | After: +0.57% | Quantum | $1.36B | xxxxxxxxxxxxx | |||||
 | $17.50 | After: 0% | Seanergy Maritime | $386.13M | xxxxxxxxxxxxx | |||||
 | $1.51 | After: 0% | Cellectar Biosciences | $16.82M | xxxxxxxxxxxxx | |||||
 | $0.32 | After: +3.24% | Rekor Systems | $51.12M | xxxxxxxxxxxxx | |||||
 | $1.12 | After: 0% | Imunon | $7.18M | xxxxxxxxxxxxx | |||||
 | $3.29 | After: 0% | Eagle Point Credit Company | $453.57M | xxxxxxxxxxxxx | |||||
 | $2.29 | After: 0% | Fate Therapeutics | $277.98M | xxxxxxxxxxxxx | |||||
 | $4.48 | After: -1.15% | Arbutus Biopharma | $881.57M | xxxxxxxxxxxxx | |||||
 | $35.56 | After: 0% | Globant SA | $1.52B | xxxxxxxxxxxxx | |||||
 | $2.05 | After: 0% | Aytu BioScience | $22.49M | xxxxxxxxxxxxx | |||||
 | $0.51 | Reviva Pharmaceuticals Holdings | $6.56M | xxxxxxxxxxxxx | ||||||
 | $7.55 | After: 0% | Precigen | $3.06B | xxxxxxxxxxxxx | |||||
 | $0.29 | After: -2.95% | GeoVax Labs | $3.23M | xxxxxxxxxxxxx | |||||
 | $3.87 | After: 0% | Clene | $57.99M | xxxxxxxxxxxxx | |||||
 | $2.06 | After: 0% | Grace Therapeutics | $43.54M | xxxxxxxxxxxxx | |||||
 | $4.68 | After: 0% | Evolv Technologies Holdings | $827.75M | xxxxxxxxxxxxx | |||||
 | $37.29 | After: +0.43% | Brookfield Corporation | $90.56B | xxxxxxxxxxxxx | |||||
 | $0.25 | After: +0.6% | VistaGen Therapeutics | $12.47M | xxxxxxxxxxxxx | |||||
 | $156.64 | Siemens AG | $236.13B | xxxxxxxxxxxxx | ||||||
 | $8.11 | After: 0% | Q32 Bio | $245.00M | xxxxxxxxxxxxx | |||||
 | $2.18 | After: 0% | Sintx Technologies | $14.73M | xxxxxxxxxxxxx | |||||
 | $3.17 | After: 0% | Incannex Healthcare Limited Sponsored ADR | $40.27M | ― | xxxxxxxxxxxxx | ||||
 | $2.73 | After: 0% | Protalix | $218.35M | xxxxxxxxxxxxx | |||||
 | $18.31 | After: 0% | Vor Biopharma | $1.11B | xxxxxxxxxxxxx | |||||
 | $1.04 | After: -0.48% | PDS Biotechnology | $41.89M | xxxxxxxxxxxxx | |||||
 | $0.64 | After: 0% | Aterian | $170.11M | xxxxxxxxxxxxx | |||||
 | $1.86 | After: 0% | Acrivon Therapeutics, Inc. | $85.28M | xxxxxxxxxxxxx | |||||
 | $18.51 | After: 0% | Omeros | $1.35B | xxxxxxxxxxxxx | |||||
 | $1.42 | After: 0% | Equillium | $89.41M | xxxxxxxxxxxxx | |||||
 | $16.76 | Peyto Exploration & Dev | C$3.39B | xxxxxxxxxxxxx | ||||||
 | $1.24 | After: 0% | Vivani Medical | $110.95M | xxxxxxxxxxxxx | |||||
 | $10.39 | After: +0.48% | TSS | $288.96M | xxxxxxxxxxxxx | |||||
 | $1.35 | BioAtla | $2.18M | xxxxxxxxxxxxx | ||||||
 | $11.72 | Freehold Royalties | $1.90B | xxxxxxxxxxxxx | ||||||
 | $17.08 | After: 0% | Suburban Propane | $1.11B | xxxxxxxxxxxxx | |||||
 | $35.85 | Hydro One | C$21.39B | xxxxxxxxxxxxx | ||||||
 | $17.33 | After: 0% | WhiteFiber, Inc. | $696.55M | xxxxxxxxxxxxx | |||||
 | $2.67 | After: +1.68% | PAVmed | $22.95M | xxxxxxxxxxxxx | |||||
 | $1.57 | After: 0% | Cibus | $130.69M | xxxxxxxxxxxxx | |||||
 | $3.32 | After: +3.31% | Xos | $46.92M | xxxxxxxxxxxxx | |||||
 | $0.99 | After: -1.45% | Phio Pharmaceuticals | $11.44M | xxxxxxxxxxxxx | |||||
 | $3.57 | After: +0.41% | Sable Offshore | $673.46M | xxxxxxxxxxxxx | |||||
 | $0.24 | After: -2.92% | VolitionRX | $6.56M | xxxxxxxxxxxxx | |||||
 | $25.45 | After: +1.96% | Neurogene | $513.29M | xxxxxxxxxxxxx | |||||
 | $61.42 | AtkinsRealis | $9.63B | xxxxxxxxxxxxx | ||||||
 | $0.29 | After: +0.14% | Blaize Holdings | $69.52M | xxxxxxxxxxxxx | |||||
 | $13.18 | After: 0% | Trevi Therapeutics | $1.98B | xxxxxxxxxxxxx | |||||
 | $1.19 | After: 0% | Spero Therapeutics | $69.30M | xxxxxxxxxxxxx | |||||
 | $79.57 | After: 0% | Monopar Therapeutics Inc | $523.35M | xxxxxxxxxxxxx | |||||
 | $3.96 | After: +1.52% | Zura Bio | $393.86M | xxxxxxxxxxxxx | |||||
 | $92.34 | After: +1.51% | Kodiak Sciences | $5.94B | xxxxxxxxxxxxx | |||||
 | $2.36 | After: 0% | Companhia Energetica Minas Gerais | $7.63B | xxxxxxxxxxxxx | |||||
 | $2.92 | Fiera Capital A | C$317.18M | xxxxxxxxxxxxx | ||||||
 | $5.03 | After: +0.4% | Super League Enterprise | $14.32M | xxxxxxxxxxxxx | |||||
 | $2.87 | Diversified Royalty Corp | C$502.23M | xxxxxxxxxxxxx | ||||||
 | $2.54 | After: +0.98% | Lithium Americas Corp. | $919.01M | xxxxxxxxxxxxx | |||||
 | $10.60 | After: 0% | Meiragtx Holdings | $1.04B | xxxxxxxxxxxxx | |||||
 | $635.48 | After: +1.81% | Dillard's | $10.22B | xxxxxxxxxxxxx | |||||
 | $9.25 | After: 0% | SuperCom | $59.10M | xxxxxxxxxxxxx | |||||
 | $3.19 | After: +2.87% | SeaStar Medical Holding | $20.67M | xxxxxxxxxxxxx | |||||
 | $4.25 | After: 0% | Broadwind Energy | $100.54M | xxxxxxxxxxxxx | |||||
 | $0.49 | After: -2.62% | Flux Power Holdings | $13.84M | xxxxxxxxxxxxx | |||||
 | $11.98 | After: 0% | Oric Pharmaceuticals | $1.27B | xxxxxxxxxxxxx | |||||
 | $3.96 | After: 0% | Cytosorbents | $12.76M | xxxxxxxxxxxxx | |||||
 | $1.51 | After: 0% | Grandstand Limited | $53.00M | xxxxxxxxxxxxx | |||||
 | $37.72 | After: 0% | Brookfield Infrastructure | $4.99B | xxxxxxxxxxxxx | |||||
 | $9.87 | After: +1.42% | Candel Therapeutics | $778.96M | xxxxxxxxxxxxx | |||||
 | $13.02 | After: 0% | Boston Omaha | $397.97M | xxxxxxxxxxxxx | |||||
 | $29.84 | Deutsche Telekom | $142.52B | xxxxxxxxxxxxx | ||||||
 | $2.06 | After: +1.94% | Ballard Power Systems | $718.88M | xxxxxxxxxxxxx | |||||
 | $24.51 | After: 0% | National Energy Services Reunited | $2.49B | xxxxxxxxxxxxx | |||||
 | $98.89 | After: 0% | The Toro Company | $9.34B | xxxxxxxxxxxxx | |||||
 | $2.67 | After: 0% | Fluent | $94.19M | xxxxxxxxxxxxx | |||||
 | $27.35 | After: +0.26% | Figure Technology Solutions, Inc. Class A | $6.40B | xxxxxxxxxxxxx | |||||
 | $4.89 | After: -1.43% | Cingulate Inc | $69.22M | xxxxxxxxxxxxx |
Rows:
Earnings News
FAQ
When is Earnings Season?
The earnings season usually begins one to two weeks after the end of the last month of each quarter (December, March, June, and September).
How do earnings affect stock prices?
A company's earnings report reveals its profitability and financial stability. If a company’s earnings are reported above expectations, its stock price tends to rise. However, depending on forward guidance and macroeconomic factors, a stock price is still susceptible to volatility.
Is it better to buy a stock before or after earnings?
Stock prices tend to be more volatile before and after a company reports its earnings. Investors should develop an investment thesis using Earnings Reports Insights and other datasets before making any investment decisions.